美国与其他高收入国家的医疗保健支出比较
该分析基于2013-2016年主要来自OECD的数据,比较美国与10个最高收入国家的医疗支出驱动因素。2016年美国医疗支出占GDP的17.8%,其他国家为9.6%-12.4%。美国医保覆盖率为90%,低于其他国家的99%-100%,私人保险比例最高(55.3%)。美国医生和护士人数与其他国家相当,医院床位为2.8/1000,但MRI(118/1000)和CT(245/1000)使用率更高。美国行政成本占8%,其他国家为1%-3%;人均药品支出为1443美元,其他国家为466-939美元。结论认为美国医疗支出约为其他高收入国家的两倍,但利用率大致相似,劳动力和商品价格(包括药品)及行政成本是主要差异驱动因素。
要点
- 2016年美国医疗支出占GDP的17.8%,其他10个高收入国家为9.6%(澳大利亚)至12.4%(瑞士)。
- 美国医保覆盖率为90%,低于其他国家的99%-100%;私人保险比例最高为55.3%。
- 美国医生密度为2.6/1000(43%为初级保健医生),护士密度为11.1/1000,医院床位为2.8/1000,与其他国家相当。
- 美国MRI使用率为118/1000,CT使用率为245/1000,高于其他国家。
- 美国行政成本占8%,其他国家为1%-3%;人均药品支出为1443美元,其他国家为466-939美元。
适用人群与场景
- 美国与10个最高收入国家(英国、加拿大、德国、澳大利亚、日本、瑞典、法国、荷兰、瑞士、丹麦)的全人群比较。
研究设计与关键结果
- 研究类型为国际比较分析,数据主要来自2013-2016年OECD等国际组织,比较美国与10个高收入国家的结构性特征、医疗和社会支出类型及绩效。
- 2016年美国医疗支出占GDP的17.8%,其他国家范围为9.6%(澳大利亚)至12.4%(瑞士)。
- 美国医保覆盖率为90%,其他国家为99%-100%;美国私人保险比例最高为55.3%。
- 美国每日吸烟率(≥15岁)为11.4%,11国平均为16.6%;美国超重或肥胖成人比例为70.1%,其他国家范围为23.8%-63.4%,11国平均为55.6%。
- 美国预期寿命为78.8岁,其他国家范围为80.7-83.9岁,11国平均为81.7岁;美国婴儿死亡率为5.8/1000活产,11国平均为3.6/1000。
- 美国医生密度为2.6/1000(43%为初级保健医生),护士密度为11.1/1000,医院床位为2.8/1000;MRI使用率为118/1000,CT使用率为245/1000,高于其他国家。
- 美国每10万出院率:急性心肌梗死192、肺炎365、慢性阻塞性肺疾病230;每10万手术率:髋关节置换204、膝关节置换226、冠状动脉旁路移植术79,与其他国家相似。
- 美国行政成本占8%,其他国家为1%-3%;人均药品支出为1443美元,其他国家为466-939美元;全科医生薪资为218173美元,其他国家为86607-154126美元。
证据类型、等级与局限
- 证据类型为基于国际组织数据的分析;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Health care spending in the United States is a major concern and is higher than in other high-income countries, but there is little evidence that efforts to reform US health care delivery have had a meaningful influence on controlling health care spending and costs.
OBJECTIVE: To compare potential drivers of spending, such as structural capacity and utilization, in the United States with those of 10 of the highest-income countries (United Kingdom, Canada, Germany, Australia, Japan, Sweden, France, the Netherlands, Switzerland, and Denmark) to gain insight into what the United States can learn from these nations.
EVIDENCE: Analysis of data primarily from 2013-2016 from key international organizations including the Organisation for Economic Co-operation and Development (OECD), comparing underlying differences in structural features, types of health care and social spending, and performance between the United States and 10 high-income countries. When data were not available for a given country or more accurate country-level estimates were available from sources other than the OECD, country-specific data sources were used.
FINDINGS: In 2016, the US spent 17.8% of its gross domestic product on health care, and spending in the other countries ranged from 9.6% (Australia) to 12.4% (Switzerland). The proportion of the population with health insurance was 90% in the US, lower than the other countries (range, 99%-100%), and the US had the highest proportion of private health insurance (55.3%). For some determinants of health such as smoking, the US ranked second lowest of the countries (11.4% of the US population ≥15 years smokes daily; mean of all 11 countries, 16.6%), but the US had the highest percentage of adults who were overweight or obese at 70.1% (range for other countries, 23.8%-63.4%; mean of all 11 countries, 55.6%). Life expectancy in the US was the lowest of the 11 countries at 78.8 years (range for other countries, 80.7-83.9 years; mean of all 11 countries, 81.7 years), and infant mortality was the highest (5.8 deaths per 1000 live births in the US; 3.6 per 1000 for all 11 countries). The US did not differ substantially from the other countries in physician workforce (2.6 physicians per 1000; 43% primary care physicians), or nursing workforce (11.1 nurses per 1000). The US had comparable numbers of hospital beds (2.8 per 1000) but higher utilization of magnetic resonance imaging (118 per 1000) and computed tomography (245 per 1000) vs other countries. The US had similar rates of utilization (US discharges per 100 000 were 192 for acute myocardial infarction, 365 for pneumonia, 230 for chronic obstructive pulmonary disease; procedures per 100 000 were 204 for hip replacement, 226 for knee replacement, and 79 for coronary artery bypass graft surgery). Administrative costs of care (activities relating to planning, regulating, and managing health systems and services) accounted for 8% in the US vs a range of 1% to 3% in the other countries. For pharmaceutical costs, spending per capita was $1443 in the US vs a range of $466 to $939 in other countries. Salaries of physicians and nurses were higher in the US; for example, generalist physicians salaries were $218 173 in the US compared with a range of $86 607 to $154 126 in the other countries.
CONCLUSIONS AND RELEVANCE: The United States spent approximately twice as much as other high-income countries on medical care, yet utilization rates in the United States were largely similar to those in other nations. Prices of labor and goods, including pharmaceuticals, and administrative costs appeared to be the major drivers of the difference in overall cost between the United States and other high-income countries. As patients, physicians, policy makers, and legislators actively debate the future of the US health system, data such as these are needed to inform policy decisions.
参考来源
- Papanicolas I, Woskie LR, Jha AK, et al. Health Care Spending in the United States and Other High-Income Countries. JAMA. 2018. PMID: 29536101. doi:10.1001/jama.2018.1150
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。